Atualização sobre hemoglobina glicada (HbA 1C) para avaliação do controle glicêmico e para o diagnóstico do diabetes: aspectos clínicos e laboratoriais Update on glycated hemoglobin (HbA 1C) for assessment of glycemic control and the diagnosis of diabetes: clinical and laboratory aspects
RESUMOSessenta e seis adolescentes, sendo 38 obesos (25F/13M) e 28 não obesos (23F/5M), pareados pelo sexo, idade, cor; nível de escolaridade e estágio de maturação sexual, foram submetidos a um inquérito clínico-demográfico e à avaliação clínico-laboratorial. A relação cinturaquadril foi maior no grupo dos obesos do que nos não obesos (0,86±0,08 vs. 0,74±0,04; p< 0,01), assim como as medidas de pressão arterial sistóli-ca e diastólica (120,2±12,1 vs. 105,4±9,1mmHg; p<0,01 e 74,3±7,7 vs. 65,5±9,4mmHg; p<0,01, respectivamente). A lesão dermatológica acanthosis nigricans predominou no grupo dos obesos (n= 24, 63,2%). Os obesos apresentaram valores de HDL-colesterol inferiores aos dos não obesos (36,5+10,5 vs. 43,0±9,2mg/dl, respectivamente; p< 0,05). Os níveis de triglicerídeos e ácido úrico foram maiores no grupo dos obesos se comparado aos não obesos (124,6±80,0 vs. 74,2±31,4mg/dl, respectivamente; p< 0,01 e 5,8±1,4 vs. 4,5±1,0mg/dl, respectivamente; p< 0,01). Não houve diferença nos valores de colesterol, LDL colesterol e na glicemia basal entre os dois grupos. Os adolescentes obesos procuraram tratamento na maioria das vezes movidos por uma preocupação com a saúde (n= 15, 39,5%). Um número significativo desses adolescentes já havia feito uso de medicamentos visando a perda ponderal no passado. Concluímos que a obesidade na adolescência pode estar relacionada a um perfil clínico-metabólico desfavorável, caracterizado por níveis mais elevados de pressão arterial sistólica e diastólica, triglicerídeos, ácido úrico, e mais reduzidos de HDL-colesterol; e ainda pela presença de acanthosis nigricans. ABSTRACTSixty six adolescents, 36 obese (25F/13M) and 28 non-obese (23F/5M), matched for sex, age, race, education level and Tanner stage of sexual maturation were submitted to a demographical inquire, clinical evaluation and laboratory analysis. The waist-to-hip ratio (0.86±0.08 vs. 0.74±0.04; p< 0.01) and systolic and diastolic blood pressures (120.2±12.1 vs. 105.4±9.1 mmHg; p< 0.01 and 74.3±7.7 vs. 65.5±9.4mmHg; p< 0.01), were higher in the obese group as compared to the non-obese group. Acanthosis nigricans predominated in the obese group (n= 24; 63.5%). levels of HDL-cholesterol were lower in obese adolescents (36.5±10.5 vs. 43.0±9.2 mg/dl; p< 0.05), whereas levels of triglycerides and uric acid were higher (124.6±80.0 vs. 74.2±31.4mg/dl; p< 0.01 and 5.8±1,4 vs, 4.5±1.0mg/dl; p< 0,01), respectively. No differences were found in cholesterol, LDL-cholesterol and basal glucose between the two groups, Obese adolescents sought for treatment because of concern about their health (n= 15, 39.5%). Most of them had already used antiobesity drugs in the past. We conclude that obesity in adolescence seems to be associated with a clinical and metabolic profile of insulin resistance with
■ AbstractMajor clinical studies have shown that the targets for blood glucose, lipid profile and blood pressure in type 2 diabetic patients are difficult to maintain in clinical practice. However, there are few data concerning South American populations. Using guidelines represented by the Brazilian Diabetes Society, we evaluated cardiovascular (CV) risk factors, glycemic control and the availability of screening for diabetes complications in 2233 (60% females) outpatients with type 2 diabetes aged 59.2 ± 11.3 yr and with a known duration of diabetes of 9.2 ± 7.2 yr, collected from 8 Brazilian cities. The outcome showed that less intensive clinical care available for diabetic patients in Brazil compared to western industrialized countries leads to widespread poor metabolic control and health status. Less than 30% of the patients reached the target for systolic (28.5%, < 130 mmHg) and diastolic (19.3%, < 80 mmHg) blood pressure, BMI (24.6%, < 25 kg/m 2 ), LDL cholesterol (20.6%, < 2.6 mmol/l) and only 46% reached the goal for HbA1c (one % point above the upper limits of normality for the method used). Only 0.2% of patients reached all the targets. A lower number of women reached the targets for HbA1c, LDL and HDL cholesterol than men (p < 0.001). Women were less likely than men to have funduscopy examinations and urine albumin testing (p < 0.001). We conclude that the national goals for glycemic control, blood pressure and lipid levels are rarely achieved in clinical practice, and that the availability for diabetic complication screening is low. The quality of diabetes care, in particular for women, is poor and should be further reviewed in developing countries.
ObjectiveTo evaluate the capability of intravoxel incoherent motion (IVIM) diffusion-weighted imaging (DWI) to assess steatohepatitis and fibrosis determined by histopathology in type 2 diabetic patients.MethodsFifty-nine type 2 diabetic patients (49 women, 10 men; mean age, 54 ± 9 years) were submitted to liver biopsy for the evaluation of non-alcoholic fatty liver disease (NAFLD) and underwent DWI on a 3.0T MR system using 10 b values. Institutional approval and patient consent were obtained. Pure molecular-based (D), perfusion-related (D*), and vascular fraction (f) were calculated using a double exponential model and least squares curve fitting. D, D*, and f were compared between patients with and without steatohepatitis and between patients with and without fibrosis. The variables were compared by using the Ranksum test and Student t-test.ResultsSteatohepatitis was observed in 22 patients and fibrosis in 16 patients. A lower D median (0.70 s/mm2 vs. 0.83 s/mm2, p<0.05) and a lower D* median (34.39 s/mm2 vs. 45.23 s/mm2, p<0.05) were observed among those with steatohepatitis. A lower D median (0.70 s/mm2 vs. 0.82 s/mm2, p<0.05) and a lower D* median (35.01 s/mm2 vs. 44.76 s/mm2, p=0.05) were also observed among those with fibrosis.ConclusionIVIM-DWI has the potential to aid in the characterization of steatohepatitis and fibrosis.
Arq Bras Endocrinol Metabvol 47 nº 1 Fevereiro 2003 62 RESUMOAvaliamos a influência da gordura corporal (GC) determinada por bioimpedância, índice de massa corpórea (IMC) e a medida da cintura abdominal (CA) em determinadas variáveis clínicas e laboratoriais em 43 pacientes com diabetes tipo 2 (DM2), 26F/17M, pareados pela idade, com 13,6±9,1 anos de duração do DM. As mulheres apresentaram maior IMC: 30,3±5,4 vs. 26,9±2,9kg/m 2 (p= 0,04), GC: 35,4±6,2 vs. 19,6±6,2% (p= 0,000), níveis de colesterol total (CT): 235±41 vs. 204± 39mg/dL (p= 0,017), triglicerídeos (TG): 146± 61 vs. 116±57mg/dL (p= 0,06) e HbA1c (HPLC): 7,1±1,7 vs. 6,9±1,4% (p= 0,02) do que os homens, não havendo diferença entre HDL e LDL colesterol. A GC correlacionou-se significativamente com os níveis de TG, HbA1c, pressão arterial diastólica (PAD), IMC e CA. Na regressão múltipla com GC, CA e IMC como variáveis independentes e TG (r= 0,34; r 2 = 0,11; p= 0,02) e PAD (r= 0,39; r 2 = 0,15; p= 0,008) como dependentes, a GC foi a variável independente significativa. No mesmo modelo com a HBA1c como variável dependente, a GC (r= 0,31; r 2 = 0,10; p= 0,037) e o IMC (r= 0,43; r 2 = 0,19; p= 0,01) foram as variáveis significativas. Concluímos que o aumento da GC no paciente com DM2 constituiu um importante fator de risco para piora do controle metabólico e dos níveis tensionais. As mulheres, por terem tido maior percentual de GC e níveis de lipídios, devem ter uma abordagem mais agressiva e diferenciada para sua redução. 116± 57mg/dL (p= 0.06) and HbA1c (HPLC): 7.1±1.7 vs. 6.9±1.4% (p= 0,02) than men, but HDL and LDL cholesterol were not different. When correlated to BA, the following variables were statistically significant: TG, HbA1c, diastolic blood pressure (DBP) and WC. In the stepwise multiple regression analysis using BA, WC and BMI as independent variables and TG (r= 0.34; r 2 = 0.11; p= 0.02) and DBP (r= 0.39; r 2 = 0.15; p= 0.008) as the dependent ones, BA was found to be statistically significant. By using the same model having HbA1c as the dependent variable, BA (r= 0.31; r 2 = 0.10; p= 0.037) and BMI (r= 0.43; r 2 = 0.19; p= 0.01) became significant. In conclusion, elevated BA in patients with DM2 is an important risk factor to worse metabolic control and blood pressure levels. Women, by virtue of their greater BA and worst plasma lipid proartigo original
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.